Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats

被引:138
作者
Doi, R
Masuyama, T
Yamamoto, K
Doi, Y
Mano, T
Sakata, Y
Ono, K
Kuzuya, T
Hirota, S
Koyama, T
Miwa, T
Hori, M
机构
[1] Osaka Univ, Grad Sch Med A8, Dept Internal Med & Therapeut, Dept Med 1, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan
关键词
hypertension; heart failure; diastole;
D O I
10.1097/00004872-200018010-00016
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective There are two phenotypes of heart failure, systolic failure and isolated diastolic heart failure with preserved left ventricular systolic function. Although isolated diastolic heart failure frequently occurs, there are only models for diastolic dysfunction unassociated with heart failure and models with overt diastolic heart failure have not been established. We attempted to develop two different models, i.e. diastolic and systolic failure models, based on hypertension. Materials and methods Dahl salt-sensitive rats were placed on 8% NaCl diet from 7 weeks old (7-week starting group) or 8 weeks old (8-week starting group). As an age-matched control, Dahl salt-sensitive rats were consistently placed on normal chow. In these rats, echocardiogram was serially recorded, followed by hemodynamic and histological studies. Results The 7-week starting rats showed a steep elevation in blood pressure and progressive left ventricular hypertrophy, and fell into overt heart failure at approximately 19 weeks. The development of heart failure was not associated with a decrease in left ventricular midwall fractional shortening or an increase in left ventricular end-diastolic dimension as compared with the age-matched control, which mimics the characteristics of clinically observed isolated diastolic heart failure. The 8-week starting rats showed a gradual rise in blood pressure and less progressive left ventricular hypertrophy, and fell into heart failure at approximately 26 weeks with a decrease in mid-wall fractional shortening and an increase in left ventricular end-diastolic dimension. Hemodynamic and histological studies at failing stage revealed comparable elevation of left ventricular end-diastolic pressure and comparable left ventricular fibrosis in both groups, Conclusion These two different models of overt heart failure may be useful as models of isolated diastolic heart failure and systolic heart failure based on the same hypertensive heart disease, respectively, and may contribute to discrimination of the mechanisms of the development of the two different phenotypes of heart failure. J Hypertens 2000, 18:111-120 (C) Lippincott Williams & Wilkins.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 50 条
  • [21] Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats
    Xu, JL
    Nagata, K
    Obata, K
    Ichihara, S
    Izawa, H
    Noda, A
    Nagasaka, T
    Iwase, M
    Naoe, T
    Murohara, T
    Yokota, M
    HYPERTENSION, 2005, 46 (04) : 719 - 724
  • [22] Dysfunction of paracellin-1 by dephosphorylation in Dahl salt-sensitive hypertensive rats
    Ikari, Akira
    Matsumoto, Satomi
    Harada, Hitoshi
    Takagi, Kuniaki
    Degawa, Masakuni
    Takahashi, Tadanobu
    Sugatani, Junko
    Miwa, Masao
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2006, 56 (05) : 379 - 383
  • [23] Crucumin, a natural p300-specific HAT inhibitor, is a therapeutic agent that prevents the development of heart failure in salt-sensitive Dahl rats
    Morimoto, Tatsuya
    Fujita, Masatoshi
    Kita, Toru
    Kawamura, Teruhisa
    Wada, Hiromichi
    Sunagawa, Yoichi
    Hasegawa, Koji
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (06) : 1059 - 1060
  • [24] Beneficial effects of the combination of nifedipine and losartan in hypertensive dahl salt-sensitive rats
    Tinel, Hanna
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (01) : 75 - 82
  • [25] Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats
    Suzuki, Takeya
    Akasaka, Yoshikiyo
    Namiki, Atsushi
    Ito, Kinji
    Ishikawa, Yukio
    Yamazaki, Junichi
    Ishii, Toshiharu
    JOURNAL OF HYPERTENSION, 2008, 26 (12) : 2436 - 2444
  • [26] Expression of Proinflammatory Cytokines Is Upregulated in the Hypothalamic Paraventricular Nucleus of Dahl Salt-Sensitive Hypertensive Rats
    Jiang, Enshe
    Chapp, Andrew D.
    Fan, Yuanyuan
    Larson, Robert A.
    Hahka, Taija
    Huber, Michael J.
    Yan, Jianqun
    Chen, Qing-Hui
    Shan, Zhiying
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [27] Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade
    Guo, Peng
    Nishiyama, Akira
    Rahman, Matlubur
    Nagai, Yukiko
    Noma, Takahisa
    Namba, Tsunetatsu
    Ishizawa, Makoto
    Murakami, Kazushi
    Miyatake, Akira
    Kimura, Shoji
    Mizushige, Katsufumi
    Abe, Youichi
    Ohmori, Koji
    Kohno, Masakazu
    JOURNAL OF HYPERTENSION, 2006, 24 (06) : 1097 - 1104
  • [28] Differential induction of protein kinase C isoforms at the cardiac hypertrophy stage and congestive heart failure stage in Dahl salt-sensitive rats
    Koide, Y
    Tamura, K
    Suzuki, A
    Kitamura, K
    Yokoyama, K
    Hashimoto, T
    Hirawa, N
    Kihara, M
    Ohno, S
    Umemura, S
    HYPERTENSION RESEARCH, 2003, 26 (05) : 421 - 426
  • [29] Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats
    Takatsu, Miwa
    Hattori, Takuya
    Murase, Tamayo
    Ohtake, Masafumi
    Kato, Miki
    Nashima, Keigo
    Nakashima, Chieko
    Takahashi, Keiji
    Ito, Hiromi
    Niinuma, Kazumi
    Aritomi, Shizuka
    Murohara, Toyoaki
    Nagata, Kohzo
    JOURNAL OF HYPERTENSION, 2012, 30 (09) : 1845 - 1855
  • [30] The frequency of systolic versus diastolic heart failure in an Egyptian cohort
    Ibrahim, BS
    EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (01) : 41 - 45